Cardiovascular Kidney Interaction
Cardiovascular Kidney Interaction - Related Videos
08:19
The Mouse Isolated Perfused Kidney Technique
0 Views •
Cited by 24 •
2016
The mouse isolated perfused kidney (MIPK) is a technique for keeping a mouse kidney under ex vivo conditions perfused and functional for 1 hr. The buffers and surgical technique are described in detail.
01:45
Kidney Structure
0 Views •
2019
The kidneys are two large bean-shaped organs located in the upper abdomen. They filter the blood several times a day to remove toxins and rebalance water and electrolytes of the circulatory system via the renal veins. The kidneys receive blood directly from the heart via the renal arteries. These arteries enter the kidney at the hilum, the concave surface of the bean, where they branch and divide into smaller vessels and capillaries. The renal cortex is the thick outer layer of the kidney. It...
10:42
Normothermic Machine Perfusion of Rat Kidneys for Transplantation
0 Views •
2026
This protocol describes the ex vivo normothermic machine perfusion of a rat kidney for subsequent transplantation into a recipient rat.
07:29
Intravascular Delivery of Biologics to the Rat Kidney
0 Views •
Cited by 1 •
2016
The administration of drugs for recovery of kidney function requires control of the localization and distribution of the therapeutic compound. Here, we describe in detail a simple technique for intrarenal delivery of drugs in rats. This procedure may be easily performed with no mortality and high reproducibility.
03:14
Vibratome Sectioning of Whole Murine Kidney: A Technique to Generate Thin Sections of Murine Kidney
0 Views •
2023
In this video, we demonstrate the vibratome sectioning of a whole mouse kidney to obtain thin slices. These sliced tissue sections can be stored at low temperatures until further downstream analysis.
FAQs
Reduced cardiac output can compromise renal perfusion, meaning the kidneys receive less blood flow. Elevated venous pressure can also impair this relationship, linking cardiovascular congestion with renal dysfunction. These changes matter because the kidneys respond by activating the renin-angiotensin-aldosterone and sympathetic nervous systems, which promote sodium retention and fluid overload. In clinical interpretation, cardiac performance and venous pressure provide context for worsening kidney function.
Activation of these systems connects impaired cardiovascular function with further fluid and vascular stress. Their activity promotes sodium retention, fluid overload, and vascular dysfunction, all of which can increase the burden on the cardiovascular system. Recognizing this response helps clinicians interpret why an initial disturbance in cardiac or renal function may produce broader changes affecting both organs.
Impaired kidney function can affect cardiovascular health through several pathways rather than a single mechanism. The overview identifies hypertension, inflammation, and electrolyte disturbances as important contributors. These changes help explain why renal dysfunction may be associated with cardiovascular complications and why clinical evaluation should consider kidney-related effects even when the initial concern appears primarily cardiac.
Recognition depends on viewing cardiac and renal findings together instead of assessing either organ in isolation. Cardiorenal syndromes are identified in the context of the bidirectional changes linking cardiac function, renal perfusion, fluid regulation, and vascular stress. Monitoring renal and cardiac biomarkers can support this assessment and help clinicians recognize clinically relevant interaction between the two organ systems.
Renal and cardiac biomarkers provide complementary information about the status of the two organs. Used together, they can help clinicians monitor changes that may reflect altered cardiac function, impaired renal involvement, or progression of their interaction. This combined perspective supports recognition of cardiorenal syndromes and helps inform treatment decisions when fluid balance, blood pressure, or organ protection is a concern.
Treatment decisions must account for the linked effects of fluid regulation and vascular pressure on both organs. Diuretics are relevant when sodium retention and fluid overload are present, while blood pressure control addresses a major pathway connecting kidney dysfunction with cardiovascular stress. Therapies selected with both organs in mind may support cardiovascular and renal protection, rather than focusing on only one system.